Eli Lilly's COVID-19 antibody shows it can prevent the disease. But will doctors use it?

Eli Lilly's COVID-19 antibody shows it can prevent the disease. But will doctors use it?: 

Eli Lilly’s bamlanivimab was the first antibody drug the FDA authorized to treat COVID-19. Now, the Indianapolis pharma has data showing the therapy prevents symptomatic infections. The catch? The data are limited to long-term care facilities, where vaccination is now underway—and despite their utility, antibodies are having a tough time catching on.